Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT00451451 · COMPLETED

Trial details

NCT number: NCT00451451
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2007-06-01
Primary completion: 2011-08-01
Enrollment: 1417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.